{
  "query_term": "RYBREVANT (amivantamab)",
  "total_count": 5,
  "returned": 5,
  "kept": 3,
  "studies": [
    {
      "nct_id": "NCT05379595",
      "title": "A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer",
      "overall_status": "RECRUITING",
      "phase": "Phase 2",
      "conditions": [
        "Advanced or Metastatic Colorectal Cancer"
      ],
      "lead_sponsor": "Janssen Research & Development, LLC",
      "collaborators": [],
      "interventions": [
        "Amivantamab IV",
        "Fluorouracil",
        "Leucovorin",
        "Oxaliplatin",
        "Irinotecan",
        "Amivantamab"
      ],
      "last_update": "2025-12-19",
      "ctgov_url": "https://clinicaltrials.gov/study/NCT05379595"
    },
    {
      "nct_id": "NCT07276399",
      "title": "A Phase 3, Randomized, Open-Label, Multicenter Study of Amivantamab in Addition to Carboplatin and Pembrolizumab, Compared to Standard of Care Platinum and Pembrolizumab and 5-FU, in Participants With Treatment-Na√Øve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma",
      "overall_status": "RECRUITING",
      "phase": "Phase 3",
      "conditions": [
        "Squamous Cell Carcinoma of Head and Neck"
      ],
      "lead_sponsor": "Janssen Research & Development, LLC",
      "collaborators": [],
      "interventions": [
        "Amivantamab",
        "Pembrolizumab",
        "Carboplatin",
        "5-Flurouracil",
        "Cisplatin"
      ],
      "last_update": "2025-12-19",
      "ctgov_url": "https://clinicaltrials.gov/study/NCT07276399"
    },
    {
      "nct_id": "NCT07227025",
      "title": "A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic Non-small Cell Lung Cancer",
      "overall_status": "RECRUITING",
      "phase": "Phase 2",
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "lead_sponsor": "Janssen Research & Development, LLC",
      "collaborators": [],
      "interventions": [
        "Amivantamab",
        "Olomorasib"
      ],
      "last_update": "2025-12-19",
      "ctgov_url": "https://clinicaltrials.gov/study/NCT07227025"
    }
  ]
}